Teladoc Health, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($74.2m)
($106.8m) -43.88%
($97.1m) +9.08%
($98.9m) -1.83%
($485.1m) -390.71%
($428.8m) +11.61%
($13.7b) -3085.58%
($220.4m) +98.39%
($1.0b) -354.35%
($200.3m) +79.99%
Depreciation, Depletion and Amortization $8.3m $19.1m $35.6m $39.0m $69.5m $204.2m $256.0m $378.0m
Depreciation $2.2m $3.8m $4.1m $3.4m $4.8m $8.9m $11.4m $21.9m
Amortization of Intangible Assets $6.1m $15.3m $31.5m $35.6m $64.7m $195.3m $244.6m $325.9m $363.4m $350.8m
Capitalized Computer Software, Amortization $46.1m $83.0m $133.0m $167.6m
Depreciation, Nonproduction $11.1m $10.2m $13.3m $378.0m
Deferred Income Tax Expense (Benefit) $510k ($591k) ($1.9m) ($10.9m) ($90.5m) $41.0m ($7.8m) ($1.9m) ($1.1m) ($41.4m) ($9.0m)
Share-based Payment Arrangement, Noncash Expense $7.7m $30.6m $43.8m $66.7m $475.5m $302.6m $217.9m $201.6m $146.0m $80.4m $56.8m
Share-based Payment Arrangement, Expense $7.7m $30.6m $43.8m $66.7m $475.5m $302.6m $217.9m $201.6m $146.0m $80.4m $56.8m
Share-based Payment Arrangement, Expensed and Capitalized, Amount $221.0m $158.7m $88.0m $56.8m
Goodwill and Intangible Asset Impairment $0
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $13.4b $0 $790.0m $71.8m $12.6m
Impairment of Intangible Assets, Finite-lived $0
Other Nonoperating Income (Expense) $5.1m ($859k) $4.4m ($6.0m) $10.4m
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts Receivable $2.9m $3.7m $10.9m $15.9m $21.1m $17.5m $61.6m $10.3m $375k ($25.1m) $5.0m
Increase (Decrease) in Inventories $24.7m $19.5m ($14.8m) ($24.1m) $9.7m ($399k) $8.2m
Increase (Decrease) in Accounts Payable ($813k) $1.5m ($391k) $905k ($88.0m) $1.2m $1.9m ($4.2m) ($10.4m) $11.5m ($17.5m)
Net Cash Provided by (Used in) Operating Activities ($51.9m)
($34.4m) +33.61%
($4.9m) +85.89%
$29.9m +714.59%
($53.5m) -279.15%
$194.0m +462.52%
$189.3m -2.42%
$350.0m +84.91%
$293.7m -16.10%
$294.4m +0.23%
$261.2m -11.27%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $2.1m $2.6m $4.0m $3.5m $4.0m $8.5m $16.5m $11.5m $10.8m $8.9m ($143.1m)
Payments to Acquire Investments $27.9m ($1.5m)
Payments to Acquire Businesses, Net of Cash Acquired $37.0m $379.4m $282.4m $11.2m $567.4m $78.7m $0 $0 $81.9m ($16.6m)
Payments for (Proceeds from) Other Investing Activities ($8.7m) ($2.5m) ($1k) $0 ($60k)
Net Cash Provided by (Used in) Investing Activities $26.1m ($448.4m) ($257.5m) $25.0m ($591.0m) ($73.0m) ($167.7m) ($156.3m) ($124.1m) ($266.0m) ($161.2m)
Cash flows from financing activities:
Repayments of Long-term Debt $17.2m $226.4m $0 $0
Gain (Loss) on Extinguishment of Debt ($9.1m) ($43.7m) $0 $0
Proceeds from Issuance of Long-term Debt $35.0m $166.7m $10k $0
Proceeds from Issuance of Common Stock $250k $258.6m $330.8m $0 $0
Proceeds from (Payments for) Other Financing Activities ($4.2m) ($2.9m) $0 ($2k) $0
Net Cash Provided by (Used in) Financing Activities $20.6m
$475.4m +2208.14%
$645.6m +35.80%
$35.1m -94.56%
$859.1m +2348.10%
$40.9m -95.23%
$6.5m -84.13%
$10.9m +67.06%
$8.3m -23.42%
($551.7m) -6736.81%
($4.1m) +99.26%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $514.4m $733.3m $893.5m $918.2m $1.1b $1.3b $781.1m $775.6m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $191k ($2.1m) $388k $4.3m ($1.8m) ($3.3m) $965k ($3.3m) $6.1m ($1.2m)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from Stock Options Exercised $2.5m $10.8m $31.3m $33.3m $54.3m $25.8m $5.9m $1.5m $3.6m $85k
Supplemental disclosure of cash flow information:
Income Taxes Paid, Net $137k $441k $1.3m $1.3m $4.0m $2.5m $7.2m $8.9m $8.7m
Additional Financial Items
Accretion Expense $262k $6.4m
Foreign Currency Transaction Gain (Loss), Realized ($100k) $100k $200k ($600k)
Gain (Loss) on Disposition of Assets $5.5m $0 $0
General and Administrative Expense $48.6m $79.8m $116.9m $157.7m $497.8m $438.0m $449.9m $464.7m $435.5m $431.9m
Goodwill $188.2m $498.5m $737.2m $746.1m $14.6b $14.5b $1.1b $1.1b $283.2m $283.2m $12.6m
Income Tax Expense (Benefit) $510k ($225k) $118k ($10.6m) ($90.9m) $44.1m ($3.8m) $760k $7.6m ($35.2m)
Interest Expense Nonoperating $23.8m $19.7m
Investment Income, Interest $46.8m $57.1m $36.8m
Realized Investment Gains (Losses) $5.9m $0 $0
Restructuring Costs $7.4m $16.9m $20.4m $18.8m
Revenue from Contract with Customer, Including Assessed Tax $417.9m $553.3m $1.1b $2.0b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.